Literature DB >> 30179114

Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.

Matthew J Barkovich1, Chin Hong Tan1, Ryan M Nillo1, Yi Li1, Duan Xu1, Christine M Glastonbury1, Orit A Glenn1, William P Dillon1, Christopher P Hess1, Sabine Mueller1, Cassie Kline1, Anders M Dale1, Terry L Jernigan1, Leo P Sugrue1, A James Barkovich1, Rahul S Desikan1.   

Abstract

Purpose To evaluate whether patients with neurofibromatosis type 1 (NF1)-a multisystem neurodevelopmental disorder with myriad imaging manifestations, including focal transient myelin vacuolization within the deep gray nuclei, brainstem, and cerebellum-exhibit differences in cortical and subcortical structures, particularly in subcortical regions where these abnormalities manifest. Materials and Methods In this retrospective study, by using clinically obtained three-dimensional T1-weighted MR images and established image analysis methods, 10 intracranial volume-corrected subcortical and 34 cortical regions of interest (ROIs) were quantitatively assessed in 32 patients with NF1 and 245 age- and sex-matched healthy control subjects. By using linear models, ROI cortical thicknesses and volumes were compared between patients with NF1 and control subjects, as a function of age. With hierarchic cluster analysis and partial correlations, differences in the pattern of association between cortical and subcortical ROI volumes in patients with NF1 and control subjects were also evaluated. Results Patients with NF1 exhibited larger subcortical volumes and thicker cortices of select regions, particularly the hippocampi, amygdalae, cerebellar white matter, ventral diencephalon, thalami, and occipital cortices. For the thalami and pallida and 22 cortical ROIs in patients with NF1, a significant inverse association between volume and age was found, suggesting that volumes decrease with increasing age. Moreover, compared with those in control subjects, ROIs in patients with NF1 exhibited a distinct pattern of clustering and partial correlations. Discussion Neurofibromatosis type 1 is characterized by larger subcortical volumes and thicker cortices of select structures. Most apparent within the hippocampi, amygdalae, cerebellar white matter, ventral diencephalon, thalami and occipital cortices, these neurofibromatosis type 1-associated volumetric changes may, in part, be age dependent. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2018        PMID: 30179114      PMCID: PMC6209062          DOI: 10.1148/radiol.2018172863

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  26 in total

1.  Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain.

Authors:  Bruce Fischl; David H Salat; Evelina Busa; Marilyn Albert; Megan Dieterich; Christian Haselgrove; Andre van der Kouwe; Ron Killiany; David Kennedy; Shuna Klaveness; Albert Montillo; Nikos Makris; Bruce Rosen; Anders M Dale
Journal:  Neuron       Date:  2002-01-31       Impact factor: 17.173

Review 2.  Neurofibromin: a general outlook.

Authors:  A B Trovó-Marqui; E H Tajara
Journal:  Clin Genet       Date:  2006-07       Impact factor: 4.438

3.  Multimodal imaging of the self-regulating developing brain.

Authors:  Anders M Fjell; Kristine Beate Walhovd; Timothy T Brown; Joshua M Kuperman; Yoonho Chung; Donald J Hagler; Vijay Venkatraman; J Cooper Roddey; Matthew Erhart; Connor McCabe; Natacha Akshoomoff; David G Amaral; Cinnamon S Bloss; Ondrej Libiger; Burcu F Darst; Nicholas J Schork; B J Casey; Linda Chang; Thomas M Ernst; Jeffrey R Gruen; Walter E Kaufmann; Tal Kenet; Jean Frazier; Sarah S Murray; Elizabeth R Sowell; Peter van Zijl; Stewart Mostofsky; Terry L Jernigan; Anders M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

4.  Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.

Authors:  Ghayda M Mirzaa; Catarina D Campbell; Nadia Solovieff; Carleton Goold; Laura A Jansen; Suchithra Menon; Andrew E Timms; Valerio Conti; Jonathan D Biag; Carissa Adams; Evan August Boyle; Sarah Collins; Gisele Ishak; Sandra Poliachik; Katta M Girisha; Kit San Yeung; Brian Hon Yin Chung; Elisa Rahikkala; Sonya A Gunter; Sharon S McDaniel; Colleen Forsyth Macmurdo; Jonathan A Bernstein; Beth Martin; Rebecca Leary; Scott Mahan; Shanming Liu; Molly Weaver; Michael Doerschner; Shalini Jhangiani; Donna M Muzny; Eric Boerwinkle; Richard A Gibbs; James R Lupski; Jay Shendure; Russell P Saneto; Edward J Novotny; Christopher J Wilson; William R Sellers; Michael Morrissey; Robert F Hevner; Jeffrey G Ojemann; Renzo Guerrini; Leon O Murphy; Wendy Winckler; William B Dobyns
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 18.302

Review 5.  Brain structure and function in neurofibromatosis type 1: current concepts and future directions.

Authors:  Jonathan M Payne; Mahendranath D Moharir; Richard Webster; Kathryn N North
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-03       Impact factor: 10.154

6.  Visuospatial processing in children with neurofibromatosis type 1.

Authors:  Amy M Clements-Stephens; Sheryl L Rimrodt; Pooja Gaur; Laurie E Cutting
Journal:  Neuropsychologia       Date:  2007-10-02       Impact factor: 3.139

7.  Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.

Authors:  D P DiPaolo; R A Zimmerman; L B Rorke; E H Zackai; L T Bilaniuk; A T Yachnis
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

8.  Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms.

Authors:  Stephan Cj Huijbregts; Marisa Loitfelder; Serge A Rombouts; Hanna Swaab; Berit M Verbist; Enrico B Arkink; Mark A Van Buchem; Ilya M Veer
Journal:  J Neurodev Disord       Date:  2015-10-15       Impact factor: 4.025

9.  Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities.

Authors:  Inês R Violante; Maria J Ribeiro; Eduardo D Silva; Miguel Castelo-Branco
Journal:  J Neurodev Disord       Date:  2013-02-13       Impact factor: 4.025

10.  The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism.

Authors:  A Di Martino; C-G Yan; Q Li; E Denio; F X Castellanos; K Alaerts; J S Anderson; M Assaf; S Y Bookheimer; M Dapretto; B Deen; S Delmonte; I Dinstein; B Ertl-Wagner; D A Fair; L Gallagher; D P Kennedy; C L Keown; C Keysers; J E Lainhart; C Lord; B Luna; V Menon; N J Minshew; C S Monk; S Mueller; R-A Müller; M B Nebel; J T Nigg; K O'Hearn; K A Pelphrey; S J Peltier; J D Rudie; S Sunaert; M Thioux; J M Tyszka; L Q Uddin; J S Verhoeven; N Wenderoth; J L Wiggins; S H Mostofsky; M P Milham
Journal:  Mol Psychiatry       Date:  2013-06-18       Impact factor: 15.992

View more
  4 in total

1.  Neuroanatomical correlates of working memory performance in Neurofibromatosis 1.

Authors:  Cameron Sawyer; Jonathan Green; Ben Lim; Gorana Pobric; JeYoung Jung; Grace Vassallo; D Gareth Evans; Charlotte J Stagg; Laura M Parkes; Stavros Stivaros; Nils Muhlert; Shruti Garg
Journal:  Cereb Cortex Commun       Date:  2022-05-19

Review 2.  Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.

Authors:  Jun Liu; Jing-Ning Huang; Ming-Han Wang; Zhen-Yang Ni; Wei-Hao Jiang; Manhon Chung; Cheng-Jiang Wei; Zhi-Chao Wang
Journal:  Front Oncol       Date:  2022-05-23       Impact factor: 5.738

Review 3.  Radiohistogenomics of pediatric low-grade neuroepithelial tumors.

Authors:  Asim K Bag; Jason Chiang; Zoltan Patay
Journal:  Neuroradiology       Date:  2021-03-29       Impact factor: 2.804

4.  NuMorph: Tools for cortical cellular phenotyping in tissue-cleared whole-brain images.

Authors:  Oleh Krupa; Giulia Fragola; Ellie Hadden-Ford; Jessica T Mory; Tianyi Liu; Zachary Humphrey; Benjamin W Rees; Ashok Krishnamurthy; William D Snider; Mark J Zylka; Guorong Wu; Lei Xing; Jason L Stein
Journal:  Cell Rep       Date:  2021-10-12       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.